Subsequently, to examine the predictive effect of HIGD1A, SUCLG2, and SLC25A24 on CRC survival when they act as signature, we grouped patients into a high-risk group and low-risk group by the median value of expression of the three genes. Here, SUCLG2 is linked to colorectal carcinoma.